Earnings ·
Quest Diagnostics reports Q3 EPS of $2.78, raises full-year revenue and adjusted EPS guidance
DGXQuest Diagnostics Inc
Quest Diagnostics reported third-quarter net revenues of $3.10 billion, a 10% increase from the prior year, driven by strong organic growth across physician, hospital, and consumer channels. Reported diluted earnings per share reached $2.78, up 28.7%, while adjusted diluted EPS was $3.00, reflecting a 15.4% gain. The company raised its full-year 2026 revenue guidance to between $12.065 billion and $12.105 billion and increased its adjusted diluted EPS outlook to between $11.25 and $11.35, citing productivity gains from automation and AI as well as expanding clinical care needs for an aging population. Quest Diagnostics is a leading provider of diagnostic information services.